Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Assets (2016 - 2022)

Historic Assets for Avadel Pharmaceuticals (AVDL) over the last 14 years, with Q3 2022 value amounting to $145.8 million.

  • Avadel Pharmaceuticals' Assets fell 4480.72% to $145.8 million in Q3 2022 from the same period last year, while for Sep 2022 it was $145.8 million, marking a year-over-year decrease of 4480.72%. This contributed to the annual value of $247.3 million for FY2021, which is 2065.61% down from last year.
  • As of Q3 2022, Avadel Pharmaceuticals' Assets stood at $145.8 million, which was down 4480.72% from $157.9 million recorded in Q2 2022.
  • Over the past 5 years, Avadel Pharmaceuticals' Assets peaked at $351.9 million during Q1 2018, and registered a low of $145.8 million during Q3 2022.
  • In the last 5 years, Avadel Pharmaceuticals' Assets had a median value of $247.3 million in 2021 and averaged $239.6 million.
  • Per our database at Business Quant, Avadel Pharmaceuticals' Assets crashed by 5065.61% in 2019 and then skyrocketed by 11017.33% in 2020.
  • Avadel Pharmaceuticals' Assets (Quarter) stood at $190.3 million in 2018, then dropped by 20.42% to $151.4 million in 2019, then skyrocketed by 105.79% to $311.6 million in 2020, then fell by 20.66% to $247.3 million in 2021, then plummeted by 41.05% to $145.8 million in 2022.
  • Its Assets stands at $145.8 million for Q3 2022, versus $157.9 million for Q2 2022 and $221.1 million for Q1 2022.